Investors & Media

Transformative science, targeted medicines

We are working to advance a deep pipeline of precision therapies, designed to allow patients to live longer, better lives. Our approach combines world-leading expertise in protein kinases with sound execution and an intense focus on discovery.

SEC filing details

Document Details

Form
10-Q
Filing Date
Jul 29, 2021
Document Date
Jun 30, 2021
Form Description
Quarterly report which provides a continuing view of a company's financial position
Filing Group
Quarterly Filings
Company
Blueprint Medicines Corp.
Issuer
Blueprint Medicines Corp